All DOACs recommended for prevention of AF-related stroke, new NICE guideline states

The National Institute for Health and Care Excellence has overturned draft guidance that once-per-day direct oral anticoagulants should only be offered if twice-daily options are not tolerated.
Apixaban is one of four direct oral anticoagulants recommended in the National Institute for Health and Care Excellence guidance

Shutterstock.com

Four direct oral anticoagulants (DOACs) are all recommended as options for people with atrial fibrillation (AF) and a CHA2DS2‑VASc score of 2 or above for the prevention of stroke, new guidance from the National Institute for Health and Care Excellence (NICE) has said.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated